Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Industry News
Share your love
Ophthalmic Devices Market Surges to USD 100.2 Billion by 2033, Propelled by 6.4% CAGR
\n \n The Ophthalmic Devices Market is witnessing robust expansion driven by rising demand for advanced eye care solutions, growing prevalence of vision disorders, and a rapidly aging population. Technological advancements such as AI-driven diagnostics, minimally invasive surgical systems, and…
Outlook Therapeutics requests Type A meeting with FDA following second CRL for ONS-5010
(Image Credit: AdobeStock) Outlook Therapeutics has requested a Type A meeting with the US Food and Drug Administration following the agency issuing a complete response letter (CRL) to its biologics license application (BLA) resubmission for ONS-5010 (bevacizumab-vikg) for the treatment…
The state of retina at ASRS 2025 with Charles C. Wykoff, MD, PhD, and Kevin Quinn
(Image credit: AdobeStock/vetrana) The annual scientific meeting of the American Society of Retina Specialists (ASRS) was held in Long Beach, California from July 30 through August 2, 2025. At this event, researchers and experts in the retina field shared data…
EyeCool Therapeutics appoints Vance Thompson, MD, to board of directors
EyeCool Therapeutics has appointed Vance Thompson, MD, founder of Vance Thompson Vision and immediate past president of the American Society of Cataract and Refractive Surgery (ASCRS), to the company’s board of directors. Thompson has personally performed more than 100,000 vision…
Vicky Demas on the importance of simplifying retinal screenings and incorporating AI
Vicky Demas, PhD, CEO of identifeye HEALTH, spoke to Ophthalmology Times about the company’s recent FDA registration and the it’s innovative retinal imaging technology. The company formally registered with the FDA, enabling them to market their device in the United…
Neurotech Pharmaceuticals appoints Peter J. McDonnell, MD, to Board of Directors
Photo of Peter J. McDonnell, MD, provided by Neurotech and used with permission Neurotech Pharmaceuticals, Inc., has appointed had Peter J. McDonnell, MD, to the Board of Directors. McDonnell, along with being a long-time member of the Ophthalmology Times Editorial…
EMA grants Orphan designations to MCO-010, FDA grants RMAT in Stargardt disease
(Image credit: AdobeStock/Pete) The European Medicines Agency (EMA) granted Orphan designations to MCO-010 (sonpiretigene isteparvovec) across 5 categories of retinal dystrophies. The US Food and Drug Administration (FDA) also granted RMAT designation for MCO-010 in Stargardt disease (SD). The EMA…
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – The Globe and Mail
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones The Globe and Mail Source: Author: | Date: 2025-09-02 12:12:00 Source: Author: | Date: 2025-09-02 12:12:00
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – Company Announcement – FT.com – Financial Times
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – Company Announcement – FT.com Financial Times Source: Author: | Date: 2025-09-02 12:00:00 Source: Author: | Date: 2025-09-02 12:00:00
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – Laotian Times
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones Laotian Times Source: Author: | Date: 2025-09-02 12:00:00 Source: Author: | Date: 2025-09-02 12:00:00